Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jose Merino
Institution:
Hospital Universitario Fundación Jiménez Díaz
Observed institution:
Hospital Universitario Fundación Jiménez Díaz
ORCID:
0000-0002-7124-3718
Observed ORCID:
0000-0002-7124-3718
OpenAlex ID:
A5123412582
Gemcitabine plus selinexor in selective advanced sarcomas: a phase I of the Spanish group for research on sarcoma study
2026
·
Javier Martin-Broto
, Antonio Casado
, et al.
·
Nature Communications
·
3
PDF
IMMUNOSARC II Master Trial: Phase II Study of Sunitinib and Nivolumab in Clear Cell Sarcoma Cohort
2026
·
Javier Martin-Broto
, Sandra J. Strauss
, et al.
·
癌症:英文版
·
2
Safety and Efficacy of Epirubicin, Ifosfamide, and Nivolumab as First-Line Treatment for Patients with Undifferentiated Pleomorphic Sarcoma
2026
·
Javier Martin-Broto
, Javier Martinez-Trufero
, et al.
·
Clinical Cancer Research
Show more works
View as search
Works count:
3
Citation count:
5
H-index:
2
I10-index:
Year
Topic
Type